↓ Skip to main content

Cochrane Database of Systematic Reviews

Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, June 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
twitter
11 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
44 Mendeley
Title
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, June 2023
DOI 10.1002/14651858.cd012066.pub3
Pubmed ID
Authors

Nobuhiko Fukuda, Nobuyuki Horita, Ayami Kaneko, Atsushi Goto, Takeshi Kaneko, Erika Ota, Kayleigh M Kew

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 13 30%
Student > Master 5 11%
Researcher 4 9%
Other 2 5%
Student > Ph. D. Student 2 5%
Other 2 5%
Unknown 16 36%
Readers by discipline Count As %
Unspecified 13 30%
Medicine and Dentistry 8 18%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Nursing and Health Professions 1 2%
Psychology 1 2%
Other 3 7%
Unknown 17 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 41. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2024.
All research outputs
#1,017,500
of 25,655,374 outputs
Outputs from Cochrane database of systematic reviews
#2,035
of 13,151 outputs
Outputs of similar age
#20,416
of 387,763 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 123 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 387,763 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.